Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_4909
http://purl.obolibrary.org/obo/CHEBI_4909
|
|---|---|
| Preferred Name | etodolac |
| Synonyms |
ETODOLIC ACID
1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
etodolaco
(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
C17H21NO3
ETODOLAC
etodolacum
1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid
(+-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
etodolac
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | etodolac
|
|---|---|
| label | etodolac
|
| ATCCode | M01AB08
|
| Definition | Acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
|
| altId | CHEBI:126431
|
| has effect |
See more
See less
|
| has pharmacological target | |
| inhibits | |
| type | |
| has role | |
| InChIKey | InChIKey=NNYBQONXHNTVIJ-UHFFFAOYSA-N
|
| is metabolised by | |
| AHFScode | 28:08.04.92
|
| Synonym |
ETODOLIC ACID
1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
etodolaco
(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
C17H21NO3
ETODOLAC
etodolacum
1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid
(+-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
etodolac
See more
See less
|
| xref |
Wikipedia:Etodolac
PharmGKB:PA449550
ChemSpider:3192
National Drug Code Directory:0228-2599-11
Patent:DE2301525
Patent:US3939178
ChEMBL:15369391
PubChem Compound:3308
ChEMBL:2527995
RxList:http://www.rxlist.com/cgi/generic/etodolac.htm
Wikipedia:http://en.wikipedia.org/wiki/Etodolac
DrugBank:DB00749
KEGG DRUG:D00315
Drugs.com:http://www.drugs.com/etodolac.html
PubChem Substance:46505184
ChEBI:4909
ChEMBL:2970548
BindingDB:50016799
Drugs Product Database (DPD):2242915
CASRN:41340-25-4
See more
See less
|
| CASRN | 41340-25-4
|
| prefixIRI | obo2:CHEBI_4909
|
| related with | |
| SMILES |
CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12
CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1
|
| may interact with |
See more
See less
|
| DBname | etodolac
|
| InChI | InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)
|
| DBBrand |
ultradol
etodolac [usan:ban:inn]
etodolacum [inn-latin]
lodine
etodolic acid
lodine xl
etodolaco [inn-spanish]
etodolacetodolic acid
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |